About GeneMax Corp.: GeneMax Corp. is a biotechnology company specializing in the discovery and development of immunotherapeutics aimed at the treatment and eradication of cancer, and therapies for infectious diseases, autoimmune disorders and transplant tissue rejection. It is currently producing and testing a cancer vaccine in anticipation of clinical trials.
| Website | http://www.genemax.com |
| Revenue | $8 million |
| Employees | View employees |
| Address | 1135 Terminal Way Ste 209, Reno, Nevada 89502, US |
| Phone | +1 775-332-3325 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | 23andMe Inc, Ancestry, MyHeritage, Genetic Technologies Ltd, Pathway Genomics Corporation, Color, Illumina, Guardant Health, Fulgent Genetics, Invitae +30 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular GeneMax Corp. employee's phone or email?
GeneMax Corp. Questions
The GeneMax Corp. annual revenue was $8 million in 2026.
GeneMax Corp. is based in Reno, Nevada.
The NAICS codes for GeneMax Corp. are [3254, 32, 325].
The SIC codes for GeneMax Corp. are [28, 283].
